DHR Health Joins Other Texas Hospitals in Mandatory COVID-19 Vaccinations of Workforce

Community News
118

Translate to Spanish or other 102 languages!

DHR Health announces COVID-19 Vaccination requirement for all employees. Image for Illustration purposes

Mega Doctor News

- Advertisement -

EDINBURG, TX – The health and safety of our patients, employees and community is our top priority. The vaccine remains the best line of defense against severe illness due to COVID-19.

DHR Health announced that it will implement a COVID-19 vaccination requirement of all employees, unless they have an approved exemption.

We understand there may be employees who cannot get vaccinated because of medical issues or religious beliefs, and DHR Health has policies in place to address these situations on an individual basis.

- Advertisement -

Given the current status of the pandemic, DHR Health believes the vaccines are the most effective way to protect patients and staff, and promote a healthier community. We join dozens of well-respected health systems across the state in implementing this mandate.

Manish Singh, MD

CEO

DHR Health

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Antibodies elicited by COVID-19 vaccination effective against delta variant
Next article
8 weeks of meditation studies can make your brain quicker

More Articles

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.
- Advertisement -